Status:
COMPLETED
Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Alberta Health services
Conditions:
Acute Respiratory Distress Syndrome
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Treatment of patients with Hypoxemic respiratory failure (HRF) and Acute Respiratory Distress Syndrome (ARDS) is complex. Therapies that have been shown to save the lives of patients with HRF and ARDS...
Detailed Description
Hypoxemic respiratory failure (HRF) and ARDS are common conditions among patients admitted to the Intensive care unit (ICU). Treatment of these patients is complex. Evidence based therapies that can i...
Eligibility Criteria
Inclusion
- Foothills Medical Center Intensive Care Unit (Pod A)
- Invasively mechanically ventilated
Exclusion
- none
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
920 Patients enrolled
Trial Details
Trial ID
NCT04070053
Start Date
August 23 2019
End Date
March 30 2022
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Hospital Intensive Care Unit
Calgary, Alberta, Canada, T2N 2T9